Group 1 - The company received a civil ruling from the Nantong Intermediate People's Court on December 31, 2025, accepting the reorganization application [1] - According to the Shenzhen Stock Exchange's Growth Enterprise Market listing rules, the company's stock will be suspended for one day starting January 5, 2026, and will resume trading on January 6, 2026, with a delisting risk warning [1] - The stock's abbreviation will change to "*ST金灵," while the security code remains "300091," and the daily price fluctuation limit will still be 20% [1]

证券代码：300091 证券简称：金通灵 公告编号 2025-058 金通灵科技集团股份有限公司 关于启动重整阶段债权申报及召开第一次债权人会议的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 特别提示： 1.2025 年 12 月 31 日，金通灵科技集团股份有限公司（以下简称"公司"或"金通 灵"）收到江苏省南通市中级人民法院（以下简称"南通中院"或"法院"）作出的（2025） 苏 06 破 56 号《裁定书》及《决定书》，获悉南通中院裁定受理申请人上海创亚物 流有限公司对公司的重整申请，并指定金通灵科技集团股份有限公司清算组担任重 整期间的管理人（以下简称"管理人"）。 公司债权人请于 2026 年 2 月 1 日（含当日）前，根据《金通灵科技集团股份有 限公司重整案债权申报指引》（以下简称《债权申报指引》）向管理人申报债权， 书面说明债权金额、债权性质、是否有担保或连带债务人等事项，并提供相关证据 材料。 为提高申报效率、节约债权人申报成本，本次债权申报采取"网络提交+线下邮 寄"方式进行。债权人在指定线上申报系统"e 破通"提交申报材料后，将由 ...

证券代码：300091 证券简称：金通灵 公告编号：2025-057 金通灵科技集团股份有限公司 关于法院同意公司在重整期间继续营业及 自行管理财产和营业事务的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 特别提示： 1. 金通灵科技集团股份有限公司（以下简称"公司"）于 2025 年 12 月 31 日收 到南通市中级人民法院（以下简称"南通中院"或"法院"）送达的（2025）苏 06 破 56 号《民事裁定书》及《决定书》，南通中院裁定受理申请人对公司的重整申请， 并指定公司预重整阶段的临时管理人金通灵科技集团股份有限公司清算组担任公司 管理人。 2. 2025 年 12 月 31 日，公司收到南通中院送达的（2025）苏 06 破 56 号《复函》 及（2025）苏 06 破 56 号之一《决定书》，南通中院许可公司在重整期间继续营业， 并准许公司在管理人的监督下自行管理财产和营业事务。 3. 法院裁定公司进入重整程序后，公司仍存在因重整失败而被宣告破产的风险。 如后续被宣告破产，公司将被实施破产清算，根据《上市规则》第 10.4.18 条的规定 ...

证券代码：300091 证券简称：金通灵 公告编号：2025-056 金通灵科技集团股份有限公司 关于公司股票被实施退市风险警示暨停牌的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 特别提示： 1. 金通灵科技集团股份有限公司（以下简称"公司"）于 2025 年 12 月 31 日收 到南通市中级人民法院（以下简称"南通中院"或"法院"）送达的（2025）苏 06 破 56 号《民事裁定书》，南通中院裁定受理申请人对公司的重整申请。 2. 因公司被法院裁定受理重整，根据《深圳证券交易所创业板股票上市规则》 （以下简称"《上市规则》"）第 10.4.1 条的规定，公司股票于 2026 年 1 月 5 日停 牌一天，自 2026 年 1 月 6 日开市起复牌。 3. 自 2026 年 1 月 6 日开市起，公司股票交易被实施退市风险警示，股票简称由 "金通灵"变更为"*ST 金灵"，证券代码仍为"300091"，股票日涨跌幅限制仍 为 20%。 一、股票的种类、简称、股票代码、公司股票停复牌起始日、被实施退市风险 警示的起始日以及日涨跌幅限制 1. 股票种 ...

金通灵科技集团股份有限公司 关于法院裁定受理公司重整并指定管理人的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 特别提示： 1. 金通灵科技集团股份有限公司（以下简称"公司"）于 2025 年 12 月 31 日收 到南通市中级人民法院（以下简称"南通中院"或"法院"）送达的（2025）苏 06 破 56 号《民事裁定书》及《决定书》，南通中院裁定受理申请人对公司的重整申请， 并指定公司预重整阶段的临时管理人金通灵科技集团股份有限公司清算组担任公司 管理人。 2. 因公司被法院裁定受理重整，根据《深圳证券交易所创业板股票上市规则》 （以下简称"《上市规则》"）第 10.4.1 条的规定，公司股票将于 2026 年 1 月 5 日 停牌一天，并自 2026 年 1 月 6 日复牌交易起被实施退市风险警示，股票简称变更为 "*ST 金灵"，证券代码仍为"300091"，股票日涨跌幅限制仍为 20%。 3. 法院裁定公司进入重整程序后，公司仍存在因重整失败而被宣告破产的风险。 如后续被宣告破产，公司将被实施破产清算，根据《上市规则》第 10.4.18 条的规 ...

Core Viewpoint - The article discusses the recent ruling by the Nanjing Intermediate Court regarding the special representative lawsuit against Jintongling Securities, which resulted in over 43,000 investors receiving compensation exceeding 770 million yuan, highlighting the increasing application of special representative lawsuits in China's capital market [1][2]. Group 1: Legal Developments - The Nanjing Intermediate Court's ruling is a preliminary judgment that establishes the liability of the listed company, with further judgments on the responsibilities of the company's executives and related intermediaries to follow [2]. - The special representative lawsuit system is recognized as a significant method for holding financial fraud accountable, enhancing the cost of violations in the capital market, and protecting the rights of small and medium investors [3][4]. Group 2: Regulatory Context - The recent ruling aligns with the new "National Nine Articles," which aims to strengthen the regulatory framework against financial fraud and improve the accountability mechanisms in the capital market [4][5]. - The China Securities Regulatory Commission (CSRC) has adopted a "zero tolerance" approach towards financial fraud, increasing enforcement efforts and enhancing civil liability support mechanisms, including the application of special representative lawsuits [4][5]. Group 3: Case Examples - The Jintongling case involved six years of financial fraud, with the company inflating revenue by over 1.3 billion yuan and profits by 500 million yuan, currently undergoing bankruptcy restructuring [5]. - Other notable cases include Kangmei Pharmaceutical and Meishang Ecological, which are also significant financial fraud cases under special representative lawsuits [5]. Group 4: Investor Protection Initiatives - The China Securities Investor Services Center plays an active role in representing investors in lawsuits, focusing on establishing suitable plaintiffs, preparing legal arguments, and ensuring effective communication with represented investors [6][7]. - The Supreme Court and CSRC have emphasized the importance of supporting investor protection institutions in ordinary representative lawsuits, enhancing the collaborative effect of both special and ordinary representative lawsuits in safeguarding investor rights [7]. Group 5: Future Directions - There is a call for timely modifications to the judicial interpretations of representative lawsuits to refine the conditions for initiating special representative lawsuits and improve the operational mechanisms [10]. - The China Securities Investor Services Center plans to update its business rules to enhance the selection criteria and mechanisms for representative lawsuits, ensuring a solid foundation for the regular advancement of these lawsuits [10].

Group 1 - The Nanjing Intermediate People's Court ruled on December 31, 2025, that over 43,000 investors in Jintongling (300091) will receive compensation exceeding 770 million yuan due to securities fraud [1][2] - This ruling is a preliminary judgment focusing on the company's liability, with further judgments pending regarding the responsibilities of the company's former executives and related intermediaries [1][2] - The case highlights the increasing application of representative litigation in China, moving from pilot exploration to a more standardized approach [1][2] Group 2 - The new "National Nine Articles" emphasizes the establishment of a comprehensive system to combat financial fraud and strengthen accountability in the capital market [2] - The China Securities Regulatory Commission (CSRC) has adopted a "zero tolerance" policy towards financial fraud, increasing regulatory enforcement and civil accountability mechanisms [2] - Jintongling has been involved in financial fraud for six consecutive years, inflating revenue by over 1.3 billion yuan and profits by 500 million yuan, and is currently undergoing bankruptcy restructuring [2] Group 3 - The special representative litigation system is seen as a significant tool for increasing the costs of illegal activities in the capital market and protecting the rights of small and medium investors [3] - Investor protection agencies play a crucial role in the representative litigation process, leveraging their public interest functions and professional advantages [4] - The China Securities Investor Services Center has been actively involved in representative litigation, ensuring fair compensation for affected investors [5] Group 4 - The Supreme Court and the CSRC have issued guidelines to support investor protection agencies in fulfilling their roles in representative litigation [6] - There is a growing emphasis on the effectiveness of ordinary representative litigation in resolving collective securities disputes and protecting investor rights [6] - The China Securities Investor Services Center has increased its involvement in ordinary representative litigation, enhancing the collaborative effect of both types of litigation [6] Group 5 - The Supreme Court's 2020 judicial interpretation of representative litigation has played a significant role in enforcing securities laws and facilitating investor rights protection [7] - There is a need to refine the judicial interpretation to better define the conditions for initiating special representative litigation and improve the coordination between different types of representative litigation [7] - The China Securities Investor Services Center plans to modify relevant business rules to enhance the selection criteria and mechanisms for representative litigation cases [8]

Group 1 - The China Securities Regulatory Commission (CSRC) has commented on the first-instance judgment in the Jin Tong Ling Securities false statement representative litigation case, marking it as another significant case following Kangmei Pharmaceutical and Zeda Yisheng, which utilizes the special representative litigation procedure for securities false statement liability disputes [1] - The CSRC emphasized that the Jin Tong Ling case effectively demonstrates the function of the special representative litigation system in protecting investors' rights and resolving disputes through a collective and low-cost approach, thereby serving as a strong deterrent against potential violations in the securities market [1] Group 2 - The CSRC also addressed the announcement by the Shenyang Intermediate People's Court regarding the Jinzhou Port securities false statement liability dispute, highlighting the severe disruption to market order and harm to investors' rights caused by the false statements [2] - The CSRC confirmed that over 50 investors authorized the China Securities Investor Service Center to apply for the conversion of the case to a special representative litigation, effectively implementing the new "National Nine Articles" directive to enhance the application of the special representative litigation system [2] - The CSRC will continue to support the China Securities Investor Service Center in fulfilling its legal public service role in representing investors in civil litigation, promoting judicial cooperation to better protect the rights of investors, especially small and medium-sized investors [2] Group 3 - On December 30, Wenkang Securities announced the establishment of a special fund for advance compensation related to Guangdao Digital's false statements, with the China Securities Investor Protection Fund acting as the fund manager [3] - The advance compensation mechanism is recognized under the Securities Law as a means to diversify the resolution of securities disputes, where the controlling shareholders and relevant securities companies voluntarily commit to advance compensation for investors [3] - The CSRC supports market institutions in proactively engaging in advance compensation efforts to effectively resolve market disputes and maintain investors' rights [3]

光大证券公告称，其作为金通灵公司2018年相关项目独立财务顾问，是26名被告之一。2025年12月31 日，公司收到南京中院一审判决，被告金通灵公司需赔偿叶小明等43269名投资者投资损失7.75亿元， 并承担相关费用。对公司等其他25名被告承担民事赔偿责任的诉讼请求将继续审理并另制文书。因最终 涉诉金额不确定，暂无法判断对公司利润的影响。截至公告日，公司及控股子公司无应披露未披露的重 大诉讼、仲裁事项。 ...

Core Viewpoint - The China Securities Regulatory Commission (CSRC) views the recent ruling in the Jintongling Securities false statement representative lawsuit as a significant development in the enforcement of securities law, following similar cases involving Kangmei Pharmaceutical and Zeda Yisheng [1] Group 1: Legal Implications - The Jintongling case represents the third instance of a substantive judgment under the special representative lawsuit procedure for securities false statement liability disputes [1] - The case effectively demonstrates the function of the special representative lawsuit system in allowing collective low-cost protection of investor rights and resolving disputes [1] Group 2: Regulatory Perspective - The CSRC emphasizes that the special representative lawsuit system serves as an important legal mechanism for the coordinated governance of securities market regulation and judicial adjudication [1] - This ruling is expected to deter potential violations in the securities market by reinforcing the legal consequences of false statements [1]